These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11976981)

  • 1. Brain-derived neurotrophic factor is not altered in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z
    Neurol Sci; 2002 Mar; 22(6):473-4. PubMed ID: 11976981
    [No Abstract]   [Full Text] [Related]  

  • 2. GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Grundström E; Lindholm D; Johansson A; Blennow K; Askmark H
    Neuroreport; 2000 Jun; 11(8):1781-3. PubMed ID: 10852244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis.
    Johansson A; Larsson A; Nygren I; Blennow K; Askmark H
    Neuroreport; 2003 Oct; 14(14):1867-9. PubMed ID: 14534437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Total magnesium in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis].
    Iłzecka J; Stelmasiak Z; Kot A
    Neurol Neurochir Pol; 2000; 34(4):699-706. PubMed ID: 11105302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTHFR C677T allelic variant is not associated with plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis.
    Bellia C; Bivona G; Caruso A; Elce A; Amato F; Spataro R; Colletti T; Pivetti A; Russo V; Scazzone C; Lo Sasso B; Castaldo G; La Bella V; Ciaccio M
    Clin Chem Lab Med; 2015 Feb; 53(3):e73-5. PubMed ID: 25229416
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
    Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
    Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis.
    de Bustos F; Jiménez-Jiménez FJ; Molina JA; Esteban J; Guerrero-Sola A; Zurdo M; Ortí-Pareja M; Tallón-Barranco A; Gómez-Escalonilla C; Ramírez-Ramos C; Arenas J; Enríquez de Salamanca R
    J Neural Transm (Vienna); 1998; 105(6-7):703-8. PubMed ID: 9826112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-annexin V antibodies in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosis.
    Iłzecka J; Stelmasiak Z
    Neurol Sci; 2003 Nov; 24(4):273-4. PubMed ID: 14658047
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis.
    Parry GJ; Rodrigues CM; Aranha MM; Hilbert SJ; Davey C; Kelkar P; Low WC; Steer CJ
    Clin Neuropharmacol; 2010; 33(1):17-21. PubMed ID: 19935406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis.
    Roos PM; Lierhagen S; Flaten TP; Syversen T; Vesterberg O; Nordberg M
    Exp Biol Med (Maywood); 2012 Jul; 237(7):803-10. PubMed ID: 22859739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine and gamma-aminobutyric acid in amyotrophic lateral sclerosis.
    Ziegler MG; Brooks BR; Lake CR; Wood JH; Enna SJ
    Neurology; 1980 Jan; 30(1):98-101. PubMed ID: 7188643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.
    Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M
    Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal fluid cells and protein in amyotrophic lateral sclerosis.
    Norris FH; Burns W; U KS; Mukai E; Norris H
    Arch Neurol; 1993 May; 50(5):489-91. PubMed ID: 8489404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis.
    Nociti V; Frisullo G; Marti A; Luigetti M; Iorio R; Patanella AK; Bianco A; Tonali PA; Grillo RL; Sabatelli M; Batocchi AP
    J Neuroimmunol; 2010 Aug; 225(1-2):149-52. PubMed ID: 20510468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kaufmann E; Boehm BO; Süssmuth SD; Kientsch-Engel R; Sperfeld A; Ludolph AC; Tumani H
    Neurosci Lett; 2004 Nov; 371(2-3):226-9. PubMed ID: 15519762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients].
    Iłzecka J; Stelmasiak Z; Dobosz B
    Neurol Neurochir Pol; 2001; 35(6):1035-43. PubMed ID: 11987700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.